Elvitegravir (EVG) Cerebrospinal Fluid (CSF) Pharmacokinetics in HIV-Infected Individuals

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

January 18, 2017

Study Completion Date

January 18, 2017

Conditions
HIV
Interventions
DRUG

Stribild

To be administered orally, once daily with food.

DRUG

Genvoya

To be administered orally, once daily with food.

Trial Locations (1)

92103

UC San Diego AntiViral Research Center, San Diego

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Gilead Sciences

INDUSTRY

collaborator

University at Buffalo

OTHER

lead

University of California, San Diego

OTHER